Why Investors are Pushing Into Psychedelic Stocks
Psilocybin has made major headlines over the last few days. Not only was it legalized in Oregon and Washington, D.C.,
Read morePsilocybin has made major headlines over the last few days. Not only was it legalized in Oregon and Washington, D.C.,
Read moreThe 5G boom could usher in a potential $12 trillion opportunity benefiting companies like Apple Inc. (NASDAQ:AAPL), Qualcomm Inc. (NASDAQ:QCOM),
Read morePandemic testing has become the new norm. “We’ve gone from 1 million to 4.5 million tests per week in the
Read moreThe fight against the health pandemic continues. We already have vaccines from Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), and Moderna Inc. (NASDAQ:MRNA). Johnson & Johnson’s (NYSE:JNJ) vaccine is reportedly effective,
Read moreAs legal cannabis goes mainstream, it’s finding its way into a good deal of medical, beauty, and even recreational products.
Read moreThe probiotics market could become a $64.02 billion market by 2022. All thanks to growing consumer awareness of its benefits,
Read morePsilocybin may not be legal for most of the U.S., but that could change. All thanks to mounting evidence that
Read moreGene editing stocks are skyrocketing. While it’s not clear why, it may be thanks in part to Ark Investment Management
Read moreShares of Inovio Pharmaceuticals (INO) were crushed earlier this week. All after the US FDA just placed its Phase 2/3
Read moreWith or without the pandemic, telehealth is here to stay, revolutionizing healthcare as we know it. According to a recent
Read more